SORBONNE UNIVERSITE (SU) - (Coördinator)
Country:
Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites
Full project pageOrganisations map overview
ICOSAGEN CELL FACTORY OU
Country:
ILTOO PHARMA
Country:
KING'S COLLEGE LONDON
Country:
MEDIZINISCHE UNIVERSITAET WIEN
Country:
UNIVERSITA DEGLI STUDI DI TRIESTE
Country:
UNIVERSITAT ZU LUBECK (UZL)
Country: